Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 (HyAzOUT): A Prospective Pragmatic Trial

NCT04334382 is registered in ClinicalTrials.gov with Intermountain Health Care, Inc. as lead sponsor.

NCT NCT04334382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04334382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 (HyAzOUT): A Prospective Pragmatic Trial
Lead sponsor
Intermountain Health Care, Inc.
Phase
Phase 3
Overall status
Unknown status
Start date
April 2, 2020
Completion date
December 31, 2021
Enrollment
1,550 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19